Ligand Binding Sites of Inducible Costimulator and High Avidity Mutants with Improved Function
暂无分享,去创建一个
[1] J. Gutiérrez-Ramos,et al. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE , 2001, Nature Immunology.
[2] J. Gutiérrez-Ramos,et al. Importance of ICOS–B7RP-1 costimulation in acute and chronic allograft rejection , 2001, Nature Immunology.
[3] R. Kroczek,et al. ICOS is critical for T helper cell–mediated lung mucosal inflammatory responses , 2001, Nature Immunology.
[4] T. Pawson,et al. ICOS is essential for effective T-helper-cell responses , 2001, Nature.
[5] G. Freeman,et al. ICOS is critical for CD40-mediated antibody class switching , 2001, Nature.
[6] J. Allison,et al. ICOS co-stimulatory receptor is essential for T-cell activation and function , 2001, Nature.
[7] H. Ochs,et al. Induction, binding specificity and function of human ICOS , 2000, European journal of immunology.
[8] U. Dianzani,et al. The T cell activation molecule H4 and the CD28‐like molecule ICOS are identical , 2000, European journal of immunology.
[9] G. Freeman,et al. Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T Cells1 , 2000, The Journal of Immunology.
[10] T. Boone,et al. Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. , 2000, International immunology.
[11] S. Lehar,et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. , 2000, Immunity.
[12] E. Clark,et al. Characterization of Human Inducible Costimulator Ligand Expression and Function1 , 2000, The Journal of Immunology.
[13] U. Dianzani,et al. Expression of the novel T cell activation molecule hpH4 in HIV-infected patients: correlation with disease status. , 2000, AIDS research and human retroviruses.
[14] H. Himmelbauer,et al. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand , 2000, European journal of immunology.
[15] S. Davis,et al. LICOS, a primordial costimulatory ligand? , 2000, Current Biology.
[16] Paul W. Wu,et al. Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor , 2000, The Journal of Immunology.
[17] G. Zhu,et al. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. , 2000, Blood.
[18] T. Mak,et al. T-cell co-stimulation through B7RP-1 and ICOS , 1999, Nature.
[19] W. Sha,et al. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. , 1999, Immunity.
[20] J. Bajorath. A Molecular Model of Inducible Costimulator Protein and Three-Dimensional Analysis of its Relation to the CD28 Family of T Cell-Specific Costimulatory Receptors , 1999 .
[21] C. Thompson,et al. The central effectors of cell death in the immune system. , 1999, Annual review of immunology.
[22] Andreas Hutloff,et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 , 1999, Nature.
[23] K. Constantine,et al. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28 , 1997, Nature Structural Biology.
[24] J. Allison,et al. Co-stimulation in T cell responses. , 1997, Current opinion in immunology.
[25] P. Linsley,et al. Molecular modeling of CD28 and three-dimensional analysis of residue conservation in the CD28/CD152 family. , 1997, Journal of molecular graphics & modelling.
[26] J. Bluestone,et al. CTLA-4 ligation blocks CD28-dependent T cell activation [published erratum appears in J Exp Med 1996 Jul 1;184(1):301] , 1996, The Journal of experimental medicine.
[27] J. Allison,et al. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells , 1996, The Journal of experimental medicine.
[28] J. Bluestone,et al. CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.
[29] P. Linsley,et al. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1 , 1994, The Journal of experimental medicine.